Colorectal cancer control: Providing adequate care to those who need it

Journal of the National Cancer Institute

Volumn 106, Issue 4, 2014, Pages

  Brawley, Otis W ^a,b  

^a AMERICAN CANCER SOCIETY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONOSCOPY; COLORECTAL TUMOR; EARLY DIAGNOSIS; EDITORIAL; HEALTH CARE PLANNING; HEALTH EDUCATION; HEALTH PROMOTION; HEALTH SERVICE; HUMAN; MASS SCREENING; MEDICALLY UNINSURED; METHODOLOGY; OCCULT BLOOD; ORGANIZATION AND MANAGEMENT; PRIMARY PREVENTION; SOCIAL PSYCHOLOGY; STANDARD; STATISTICS; UNITED STATES;

COLONOSCOPY; COLORECTAL NEOPLASMS; DELAWARE; EARLY DETECTION OF CANCER; HEALTH EDUCATION; HEALTH PROMOTION; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MASS SCREENING; MEDICALLY UNDERSERVED AREA; MEDICALLY UNINSURED; NEW YORK CITY; OCCULT BLOOD; PRIMARY PREVENTION; SOCIAL VALUES; UNITED STATES;

EID: 84898905761     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju075     Document Type: Editorial

References (23)

1. Smith RA, Brooks D, Cokkinides V, et al. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin. 2013;63(2):88-105.
2. Gupta SSD, Doubeni CA, Anderson DS, et al. Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Can Inst. 2014;106(4):dju032 doi:10.1093/jnci/dju032.
3. National Cancer Institute. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). http://seer.cancer.gov/csr/1975-20090- pops09/. Accessed March 11, 2014.
4. Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst. 1995;87(22):1686-1693.
5. Dignam JJ, Colangelo L, Tian W, et al. Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst. 1999;91(22):1933-1940.
6. Cooper GS, Koroukian SM. Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2004;100(2):418-424.
7. Polite BN, Dignam JJ, Olopade OI. Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites. Med Clin North Am. 2005;89(4):771-793.
8. Crawford SM, Sauerzapf V, Haynes R, et al. Social and geographical factors affecting access to treatment of colorectal cancer: a cancer registry study. BMJ Open. 2012;2(2):e000410
9. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627-637.
10. Steinwachs D, Allen JD, Barlow WE, et al. NIH state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening. NIH Consens State Sci Statements. 2010;27(1):1-31.
11. Grubbs SS, Polite BN, Carney J Jr, et al. Eliminating racial disparities in colorectal cancer in the real world: it took a village. J Clin Oncol. 2013;31(16):1928-1930.
12. Richards CA, Kerker BD, Thorpe L, et al. Increased screening colonos-copy rates and reduced racial disparities in the New York Citywide campaign: an urban model. Am J Gastroenterol. 2011;106(11):1880-1886.
13. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. New Engl J Med. 2000;343(22):1603-1607.
14. Neugut AI, Lebwohl B. Screening for colorectal cancer: the glass is half full. Am J Public Health. 2009;99(4):592-594.
15. Haas JS, Brawarsky P, Iyer A, et al. Association of local capacity for endos-copy with individual use of colorectal cancer screening and stage at diagnosis. Cancer. 2010;116(12):2922-2931.
16. Nadel MR, Berkowitz Z, Klabunde CN, et al. Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations. J Gen Intern Med. 2010;25(8):833-839.
17. Fisher DA, Jeffreys A, Coffman CJ, et al. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1232-1235.
18. Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008;58(1):9-31.
19. Baldwin LM, Dobie SA, Billingsley K, et al. Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst. 2005;97(16):1211-1220.
20. Schrag D, Cramer LD, Bach PB, et al. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001;93(11):850-857.
21. Hodgson DC, Zhang W, Zaslavsky AM, et al. Relation of hospital volume to colostomy rates and survival for patients with rectal cancer. J Natl Cancer Inst. 2003;95(10):708-716.
22. Dignam JJ, Polite BN, Yothers G, et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst. 2006;98(22):1647-1654.
23. Brawley OW, Virgo KS. From the guest editors: introduction for the impact of health care reform on cancer patients. Cancer J. 2010;16(6):551-553.